On Oct 18, Acelrx Pharmaceuticals Received Written Notice From Nasdaq Notifying Co That It Is Not In Compliance With Minimum Bid Price Requirement; Will Evaluate Available Options To Regain Compliance With Minimum Bid Price Requirement
10月18日,Acelrx Pharmicals收到了纳斯达克的书面通知,通知公司它不符合最低出价要求;将评估可用期权以重新遵守最低出价要求